High Purity Meloxicam Powder 99% Pure Raw CAS 71125-38-7 Anti-Inflammatory Meloxicam

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: HRK-Meloxicam
• Product Name: Meloxicam Powder
• Appearance: Yellow Crystalline Powder
• Test: HPLC
• Mf: C14h13n3o4s2
• CAS: 71125-38-7
• MW: 351.4007
• Active Ingredient: Meloxicam
• Sample: Meloxicam Avaliable
• Certificate: GMP ISO USP Bp
• Assay: 90% Min
• Grade Standard: Feed Grade, Food Grade, Medicine Grade
• Model Number: Hrk- Meloxicam
• Type of Product: Auxiliaries and Other Medicinal Chemicals
• Storage: Cool Dry Place
• Shelf Life: 2 Years Proper Storage
• Transport Package: 1kg Per Foil Bag, 10 Bags Per Carton. 25 Kg Per Dr
• Specification: 99% min Tetramisole HCl
• Trademark: Henrikang
• Origin: Shaanxi China
• Production Capacity: 500000kg/Year

Product Description

High Purity Meloxicam Powder 99% Pure Raw CAS 71125-38-7
Anti-Inflammatory Meloxicam

Product Name	Arthritis Treatment Cas 71125-38-7 Meloxicam
CAS	71125-38-7
Appearance	Yellow Crystalline Powder
Molecular formula	C14H13N3O4S2
Molecular Weight	351.4007
Assay	98%
Shelf Life	24 months when properly stored
Storage	Keep in a cool, dry, dark location

 

What is Meloxicam ?   Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and fever reducer effects. Meloxicam is an oxicam closely related to piroxicam, and falls in the enolic acid group of NSAIDs.

Function of Meloxicam

Older patients and patients with an increased risk of adverse reactions;

In elderly patients, patients with rheumatoid arthritis and ankylosing spondylitis treatment recommended dose for
7.5mg/days. Starting dose in patients with increased risk of adverse reactions to 7.5mg/days.

Patients with renal insufficiency:

Patients with severe renal failure and need dialysis, the dose should not exceed 7.5mg/days.

Patients with mild to moderate renal insufficiency do not need to adjust the dosage (such as patients with creatinine
clearance greater than 25ml/minutes).

Patients with severe renal failure without dialysis.

Patients with hepatic insufficiency: In patients with mild and moderate hepatic insufficiency no need to adjust the dose.
In patients with severe hepatic insufficiency.

Children: This product is not for use in children under 15 years of age. Meloxicam has other forms, may apply.

Application of Meloxicam

Used to treat symptoms of rheumatoid arthritis and painful osteoarthritis (degenerative joint disease, bone and joint
disease) treatment.